A batch of Stemetil 5mg tablets is being recalled, with affected packs either not containing the correct number of tablets or not containing any at all
Sanofi-Aventis Australia, in consultation with the TGA, is recalling one batch of Stemetil (prochlorperazine maleate) 5 mg tablets (batch no. 16N0060, expiry date 06/2018).
“It has been identified that this medicine may have been dispensed with a missing blister sheet, which means affected packs would not contain the correct number of tablets,” says the TGA.
“There are no issues with the quality, safety or efficacy of Stemetil tablets from the batch involved, and no other batches are included in this recall.”
Pharmacists are advised to inspect their stock and quarantine all affected packs before returning them to their wholesaler.
Given the contents are a single blister strip of 25 tablets, the most likely scenario of a missing blister is an empty box, which should be easily detectable.
“In the event that there are no anomalies with your product, you can choose to continue using it as normal,” the TGA says.
“Patients returning unused or partially used packs of Stemetil should be provided a full refund and, if possible, offered an equivalent product to ensure continuation of therapy.”
For any further questions regarding returning stock or affected batch details, contact Sanofi Product Recall Team on 1800 152 416 (9am-5pm EST).